Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LENS

Presbia (LENS) Stock Price, News & Analysis

Presbia logo

About Presbia Stock (NASDAQ:LENS)

Advanced Chart

Key Stats

Today's Range
$25.84
$25.91
50-Day Range
$0.07
$0.32
52-Week Range
$0.23
$5.50
Volume
495 shs
Average Volume
122,366 shs
Market Capitalization
$446.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

Receive LENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Presbia and its competitors with MarketBeat's FREE daily newsletter.

LENS Stock News Headlines

Contact Lens King Coupons
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Real and virtual images
Types of lens
Convex and concave lenses
See More Headlines

LENS Stock Analysis - Frequently Asked Questions

Presbia PLC (NASDAQ:LENS) issued its quarterly earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analysts' expectations of $0.04 million. Presbia had a negative trailing twelve-month return on equity of 414.02% and a negative net margin of 36,604.35%.

Presbia (LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX) and Marinus Pharmaceuticals (MRNS).

Company Calendar

Last Earnings
8/12/2016
Today
5/04/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LENS
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,410,000.00
Net Margins
-36,604.35%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
22,325.26
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
287.94

Miscellaneous

Free Float
N/A
Market Cap
$446.51 million
Optionable
Not Optionable
Beta
2.57
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:LENS) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners